Overview
- Excelsoft Technologies makes its market debut at an issue price of Rs 120 after its IPO was subscribed 43.19 times, led by 213x demand from institutional investors.
- Bharti Airtel promoter Indian Continent Investment is set to sell up to 3.43 crore shares, or 0.56% stake, via a block deal at a Rs 2,096.7 floor price to raise about Rs 7,200 crore.
- Zydus Lifesciences secured final USFDA approval for Verapamil Hydrochloride extended-release tablets in 120 mg, 180 mg and 240 mg strengths, a product with $24.5 million in annual US sales.
- NCC received a letter of acceptance worth Rs 2,062.71 crore to expand and modernize Gauhati Medical College & Hospital in Assam.
- Indian equities fell on Tuesday with the Sensex down 313.70 points to 84,587.01 and the Nifty lower by 74.70 points to 25,884.80 on futures expiry-related pressure and FII outflows.